Palantir Technologies enters the May 20 week in an uneasy equilibrium — short sellers have not backed down, options traders have pulled back from last week's bullish extreme, and the stock itself is barely moved.
The most telling development is how little has changed in short positioning. SI % FF has edged up to 2.73% from 2.45% at the May 4 earnings print — a 22% increase in share terms over the month, with the pace of accumulation sustained rather than reversing. Last week's note flagged the fastest short build in the observable window. That build has continued. Shorts added roughly 1.2 million shares in the past five days alone. The borrow market, however, offers no friction to discourage them: availability remains extraordinarily loose at 6,429% — meaning there are roughly 64 shares available to borrow for every one already borrowed. Cost to borrow sits at 0.36%, well below levels that would indicate any squeeze pressure. Shorts face no structural urgency to cover.
Options positioning has rotated back toward neutral. The put/call ratio recovered to 1.01 after dropping as low as 0.978 last week, and now runs slightly below its 20-day average of 1.06 — a z-score of -1.10. The call-heavy tilt that marked the prior week has largely unwound. This is no longer a market reaching for upside. It is closer to a market waiting. The 52-week PCR range spans 0.61 to 1.16, and the current reading sits comfortably in the middle. Neither extreme has taken over.
The Street remains sharply divided on valuation. Bulls point to earnings momentum that is genuinely exceptional — the EPS surprise factor scores in the 79th percentile, 30-day EPS momentum ranks in the 91st. Citigroup raised its target to $225 after the Q1 print, Wedbush held at $230, and Rosenblatt lifted to $225. That cluster represents real conviction at the top end. But those targets require a re-rating that the market is currently refusing to deliver. At 80x trailing earnings and 23.6x book, the stock demands a flawless execution path, and the PE has already compressed by 18 points over the past month as the price drifted. On the other side, RBC's Rishi Jaluria held his Underperform at a $90 target — a level that implies more than 30% downside from current levels. HSBC downgraded to Hold earlier in the month with a $151 target, essentially calling the stock fairly valued at best. The consensus is Hold, and that split will not resolve without a catalyst. The next one arrives June 3, when Palantir reports Q2.
Peer performance adds a layer of context. Guidewire gained 6.6% on the week and BlackLine surged 14.6%, suggesting software money is rotating into names with less demanding multiples. Applovin fell 2.8% and Procore lost 1.5%, more in line with PLTR's flat week. The divergence between PLTR and the outperforming peers is less about the AI narrative and more about where the price-to-growth tradeoff sits most comfortably right now.
Insider activity adds a modest but consistent footnote. Director Alex Moore sold approximately $2.1 million in shares on May 15, following further sales in mid-April. These are small relative to the company's register and carry low significance scores — but the pattern of regular selling by insiders has been a fixture of recent weeks, and it is not paired with any buying from any other member of the register in the visible window.
With Q2 results due June 3, the question narrowing for PLTR is whether the ongoing short build reflects fresh fundamental scepticism or simply a valuation-anchored position that needs a guidance beat — not just an earnings beat — to unwind.
See the live data behind this article on ORTEX.
Open PLTR on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
